vs
Astrana Health, Inc.（ASTH）与Solstice Advanced Materials Inc.（SOLS）财务数据对比。点击上方公司名可切换其他公司
Solstice Advanced Materials Inc.的季度营收约是Astrana Health, Inc.的1.0倍（$969.0M vs $950.5M），Astrana Health, Inc.净利率更高（0.7% vs -3.6%，领先4.3%），Astrana Health, Inc.同比增速更快（42.9% vs 6.8%），Solstice Advanced Materials Inc.自由现金流更多（$41.0M vs $-6.0M）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Solstice Advanced Materials Inc.是一家特种先进材料供应商，专注于研发、生产及销售高性能功能材料，产品覆盖可再生能源、消费电子、工业制造、先进汽车等领域，其材料解决方案可帮助全球客户提升产品耐用性与能源利用效率。
ASTH vs SOLS — 直观对比
营收规模更大
SOLS
是对方的1.0倍
$950.5M
营收增速更快
ASTH
高出36.1%
6.8%
净利率更高
ASTH
高出4.3%
-3.6%
自由现金流更多
SOLS
多$47.0M
$-6.0M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $969.0M |
| 净利润 | $6.6M | $-35.0M |
| 毛利率 | — | 32.0% |
| 营业利润率 | 1.9% | 17.9% |
| 净利率 | 0.7% | -3.6% |
| 营收同比 | 42.9% | 6.8% |
| 净利润同比 | 184.4% | -123.0% |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHSOLS
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $969.0M | ||
| Q2 25 | $654.8M | — | ||
| Q1 25 | $620.4M | — | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $907.0M | ||
| Q2 24 | $486.3M | — | ||
| Q1 24 | $404.4M | — |
净利润ASTHSOLS
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $-35.0M | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $152.0M | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $14.8M | — |
毛利率ASTHSOLS
| Q4 25 | — | — | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASTHSOLS
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 17.9% | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | 21.7% | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | — |
净利率ASTHSOLS
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | -3.6% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 16.8% | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 3.7% | — |
每股收益（稀释后）ASTHSOLS
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $417.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $3.2B |
| 总资产 | $2.2B | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHSOLS
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $417.0M | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | — |
股东权益ASTHSOLS
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $3.2B | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $3.2B | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | — |
总资产ASTHSOLS
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $5.2B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $289.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $41.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 4.2% |
| 资本支出强度资本支出/营收 | 0.3% | 25.6% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHSOLS
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $289.0M | ||
| Q2 25 | $90.9M | — | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | — | ||
| Q2 24 | $23.2M | — | ||
| Q1 24 | $6.0M | — |
自由现金流ASTHSOLS
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $41.0M | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHSOLS
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 4.2% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHSOLS
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 25.6% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHSOLS
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SOLS
| Refrigerants | $400.0M | 41% |
| Research And Performance Chemicals | $126.0M | 13% |
| Electronic Materials | $103.0M | 11% |
| Other | $89.0M | 9% |
| Services | $64.0M | 7% |
| Alternative Energy Services | $63.0M | 7% |
| Safety And Defense Solutions | $53.0M | 5% |
| Healthcare Packaging | $49.0M | 5% |
| Affiliated Entity | $22.0M | 2% |
